RE: Buyout7 Feb 2023 12:29
Buyout valuations you are all well short...
Think of the target market. Think of long term income for a pharma and diagnostic firm.
Don't think in pennies...
And it wouldn't be double IPO, or five times post tax profit. You'd be looking at five times revenue minimum. Argument for ten depending on the product and arena.
Yes it sounds bonkers from 1.7p and a 6 mil mcap. But that's why I'm not selling. And won't be no matter where it goes.
I'll keep sayin, retirement money and will refer to a post of Neilins with absurd sale valuations for other acquisitions.